The capacity-load model is a conceptual model developed to improve understanding of the life-course aetiology of noncommunicable diseases (NCDs) and their ecological and societal risk factors. The model addresses continuous associations of both (a) nutrition and growth patterns in early life and (b) lifestyle factors at older ages with NCD risk. Metabolic capacity refers to physiological traits strongly contingent on early nutrition and growth during the first 1000 days, which promote the long-term capacity for homeostasis in the context of fuel metabolism and cardiovascular health. Metabolic load refers to components of nutritional status and lifestyle that challenge homeostasis. The higher the load, and the lower the capacity, the greater the NCD risk. The model therefore helps understand dose-response associations of both early development and later phenotype with NCD risk. Infancy represents a critical developmental period, during which slow growth can constrain metabolic capacity, whereas rapid weight gain may elevate metabolic load. Severe acute malnutrition in early childhood (stunting, wasting) may continue to deplete metabolic capacity, and confer elevated susceptibility to NCDs in the long term. The model can be applied to associations of NCD risk with socio-economic position (SEP): lower SEP is generally associated with lower capacity but often also with elevated load. The model can also help explain ethnic differences in NCD risk, as both early growth patterns and later body composition differ systematically between ethnic groups. Recent work has begun to clarify the role of organ development in metabolic capacity, which may further contribute to ethnic differences in NCD risk.
Introduction
There is now compelling evidence that the risk of chronic non-communicable diseases (NCDs), such as cardiovascular disease, stroke, diabetes and hypertension, is associated both with lifestyle and living conditions in adulthood and also with patterns of nutrition and growth during early development. These scenarios are central to the 'developmental origins of adult health and disease' (DOHaD) hypothesis [1] .
Diverse physiological mechanisms have been shown to underpin such life-course associations. These include developmental alterations in DNA expression (epigenetic marks), where the contributions of specific genes can be explored [2] , development of the gut microbiome [3] , growth of organs and tissues and the setting of hormonal axes relating to growth, development, appetite and the stress response. DOHaD research has also pursued various study designs and experimental approaches, including prospective/retrospective epidemiological analyses, randomized trials, Mendelian randomization studies and tightly controlled experiments on various animal species.
Mechanistic work is clearly crucial, but conceptual models are also needed to integrate data from diverse study designs and physiological mechanisms. Among the first such models were those proposing 'critical windows' of development, during which phenotype is particularly sensitive to ecological factors, and the 'thrifty phenotype' hypothesis of Hales and Barker [4] . The latter was the first to suggest why, rather than merely how, variability in adult NCD might be shaped by developmental experience.
The thrifty phenotype hypothesis has been influential, stimulating both empirical research and further conceptual development. Hales and Barker originally addressed type 2 diabetes risk and proposed that malnutrition during foetal life and infancy compromised development of the pancreas. In the short term, the resulting energy-saving would help meet the obligatory metabolic requirements of the brain, but in the long term the cost would be poorer pancreatic function, reducing tolerance of adult obesity and energy-dense diets [4] .
Early malnutrition thus became emphasized as a key step in NCD aetiology. Initially, data appeared to support the hypothesis: low weight at birth or in infancy was associated with later diabetes risk in many cohorts [5, 6] , while animal experiments confirmed that exposure to low-protein diets during pregnancy affected insulin metabolism, pancreatic function and body fatness in the offspring [7] .
Nevertheless, early DOHaD studies did not formally test the thrifty phenotype hypothesis, rather they simply appealed to it when interpreting their findings. As larger epidemiological data sets became available, it became apparent that associations between early growth patterns and NCD risk were evident across the entire range of birth weight [5, 8, 9] . Broadly, every unit-increase in birth weight was associated with lower NCD risk. On this basis, overt foetal malnutrition could not be the primary mechanism linking developmental experience with NCD risk. Rather, simply growing during foetal life and infancy appeared broadly protective [10, 11] .
For several reasons, however, attention began to shift away from birth weight as an important marker of NCD risk. First, variability in gene expression attracted growing attention, with studies showing that nutritional exposures during the peri-conceptual period generated epigenetic effects relevant to NCD risk [12] . Since size at birth is most closely associated with nutritional experience in later pregnancy and relates poorly to growth variability in early pregnancy [13] , birth weight could not be easily linked with these epigenetic studies. Second, if the foetal development of organs such as the pancreas was important, then weight at birth and during infancy might represent an unreliable risk marker, due to confounding by variable fatness. Third, an influential statistical model was published, proposing that weight change between birth and adulthood was the primary component of growth predictive of NCD risk [14] . Seemingly consistent with that, randomized trials linked the composition of infant formula-milks with NCD risk in childhood [15] . These effects were independent of foetal growth patterns, as the trial groups had similar birth weight when the trial commenced.
However, none of these challenges actually refutes an important role of early growth variability in the aetiology of NCDs. The fact that epigenetic marks emerging in early pregnancy predict NCD risk does not preclude an independent contribution of growth variability. The statistical model emphasizing postnatal weight change should be reconsidered, because variability in body weight relates to physiology in very different ways at different life-course periods. Moreover, randomized trials of formula-milks can illustrate the role of infant nutrition in NCD aetiology but provide no information on foetal nutrition because the intervention began at birth.
Since size both in early life and adulthood is strongly predictive of NCD risk, patterns of early growth merit further attention. To this end, the capacity-load model was developed [10] .
The capacity-load model Many components of adult lifestyle and environment contribute to NCD risk, including diet, physical inactivity, psychosocial stress, smoking, air pollution, alcohol intake and exposure to infections. Collectively, all of these impose a 'metabolic load' that challenges the body's ability to maintain homoeostasis at the levels of cells, organs or tissues [10, 11] . The concept overlaps broadly with that of allostatic load [16] , but instead of emphasizing the stress response, 'metabolic load' highlights components of homoeostasis related to fuel metabolism and cardiovascular function. This makes it especially relevant to exploring the associations of dietary intake, physical activity behaviour and body composition with NCD risk-in other words, the capacity-load model is designed with the key elements of public health nutrition in mind.
The ability to tolerate metabolic load is then considered to depend on a suite of traits, collectively termed 'metabolic capacity', that enable maintenance of homeostasis [10, 11] . Consistent with the thrifty phenotype hypothesis, these traits develop during early 'critical windows', meaning that they are strongly shaped by growth patterns (and hence nutritional supply) in foetal life and infancy. Importantly, nutrition in early life has very different effects on organ phenotype compared to later life, due to fundamental changes in the nature of growth.
The classic Minnesota starvation study, performed on adults during the Second World War, demonstrated~70% loss of fat during restricted feeding, compared with onlỹ 17% loss of lean mass (27%, accounting for oedema) [17] . During subsequent refeeding, the lean deficit was fully resolved. During early life, in contrast, deficits in organ growth appear impossible to reverse subsequently, even if body weight increases. Early growth comprises an increase in cell number through cell division, known as hyperplasia, whereas later growth comprises increases in cell size or hypertrophy. The great majority of hyperplasic growth occurs during foetal life and early infancy. In the rat, for example, organ and tissue growth is entirely due to cell proliferation until~17 days after birth, with minimal change in cell size; from~17 to~40 days, cell proliferation proceeds but more slowly, and cell size increases in most organs; and from~40 days, cell proliferation slows substantially or ceases, while cells increase in size in most tissues but minimally so in most organs [18] .
Extending this approach, the effects of subjecting rats to under-nutrition at different ages were investigated [18] . Even after refeeding, rats malnourished from birth had lighter organs and fewer cells in them. In contrast, those malnourished after 65 days of life managed to regain their organ masses and cell numbers after refeeding. Hales and Barker suggested that it was through impacting hyperplasic growth and constraining cell division that early nutritional insults generated permanent metabolic defects [4] . From early childhood, the body becomes bigger, but it cannot reverse major structural 'decisions' already locked into physiology. This helps explain why early growth variability predicts NCD risk decades later.
The capacity-load model builds on these insights but emphasizes dose-response associations between early growth variability and organ phenotype [10, 11] . Many specific physiological traits scale relatively linearly with birth weight, including neonatal lean mass, nephron number in the kidney, blood vessel caliber, airway size and metabolic functions, such as insulin secretion. Broadly, the larger lean mass at birth, the more enhanced are these traits, and hence the greater the long-term homeostatic capacity. Metabolic capacity is assumed to track from infancy into adulthood but eventually deteriorates as part of the process of aging. Failure to maintain homeostasis allows the emergence of pathophysiology, eventually resulting in overt NCDs.
The duration of hyperplasic growth (effectively, the length of critical windows) may differ between specific organs. This may explain why low body weight at 1 year, indicating continued constraint of the pancreas, predicted greater diabetes risk in cohorts born in the early twentieth century [5] . In contrast, nephrogenesis ceases at birth, hence greater weight gain at any time from birth onwards cannot enhance this physiological trait and is instead associated with higher blood pressure [19] . These contrasts indicate that metabolic capacity continues to increase for some traits in early postnatal life, whereas for others metabolic load is already increasing after birth. The risk of NCDs can then be modelled as a function of metabolic load relative to metabolic capacity [10, 11] . Holding constant capacity, increasing load is predicted to increase NCD risk in dose-response manner. Equally, holding constant load, decreasing capacity is predicted to increase risk in dose-response manner. The greatest NCD risk is predicted in those with both diminished capacity and elevated load. For example, a study of Swedish men showed that the blood pressure 'penalty' for low birth weight was minimal in those of small adult size and largest in those both tall and heavy [20] . Recent large cohort studies provide stronger support, demonstrating exactly the predicted continuous relationships of both components of metabolism with diabetes ( Fig. 1 ) and hypertension risk [9, 21] . Among those maintaining a healthy phenotype in adulthood, there is negligible elevated NCD risk in association with low birth weight. This helps explain why, despite low average birth weights, NCDs remained rare in low-/middle-income countries (LMICs) until the obesity epidemic emerged.
The key difference between the thrifty phenotype hypothesis and the capacity-load model is that the former emphasis on early malnutrition is replaced by a continuous model of NCD risk. This allows us to address an issue that has proved very challenging in public health, namely, that it is difficult to define specific risk thresholds for both adult nutritional status and early growth variability. There is no clear subset of individuals with pathological traits, rather [10] ). b The model illustrated for the prospective risk of developing diabetes in three US cohorts. The right hand y axis counts an increasing number of unhealthy adult traits (high BMI, smoking, physical inactivity, high alcohol consumption, unhealthy diet) [9] (reproduced with permission from ref. [11]) statistical cut-offs are used to define high-risk groups (e.g., low birth weight, adult obesity). In reality, there is a graded increase in disease risk in association with traits such as adult body mass index (BMI) and birth weight, and the same scenario applies to the other components of load (dietary intake, physical activity level, etc).
In the largest data sets, these variables often display a Jshaped association with NCD risk. For example, risk generally declines as birth weight rises, but in some populations it increases again among those with the highest birth weights [22] . In the upper range, rising birth weight is primarily attributable to adipose tissue (macrosomia, representing metabolic load) rather than organs and tissue associated with metabolic capacity. Equally, the association between BMI and NCD risk in adult life is J-shaped in the opposite direction. Over most of its range, increasing BMI is associated with elevated NCD risk; however, those with very low BMI also have perturbed metabolism [23] . There is therefore an optimum range of birth weight and BMI, and this scenario may apply to other traits, such as dietary intake and physical activity level.
Recent studies highlight the importance of these traits in explaining NCD risk. Among three US cohorts, for example, it was estimated that 66% of hypertension cases, and 81 and 94% of diabetes cases in men and women, respectively, could potentially have been prevented if people led healthy adult lifestyles (BMI, diet, physical activity, smoking, drinking) and had been born with a birth weight in the normal range [9, 21] . While the capacity-load model may not fit the data equally successfully in every population, it appears useful for explaining unequal NCD risk in association with key nutritional traits within populations.
So far, I have emphasized the contribution of growth traits to metabolic capacity, where size in early life indicates homeostatic quality. This approach could potentially be extended to functional traits, though routinely obtaining such data in the foetus or infant remains challenging. Epigenetic marks could be explored in this context, as could various hormones or metabolic processes, such as pancreatic beta-cell function or arterial distensibility [2] . However, the predictive success of the model as described above highlights the value of birth weight as a composite marker of early development. It is precisely because so many individual traits scale relatively linearly with birth weight that this outcome, in combination with markers of load, successfully predicts adult disease. Incorporating multiple detailed predictors should be tested empirically, but it would cost more and might not perform substantially better. For both capacity and load, multiple traits could be incorporated by expressing outcomes as z-scores and then averaging them. Alernatively, Li and colleagues quantified a composite load using thresholds and summed the traits per individual categorized as unhealthy [9, 21] .
Each of capacity and load may change through the lifecourse, though to different degrees. Adults may adopt healthier lifestyles, and cohort studies indicate that these are associated with low risk of diabetes and hypertension, regardless of birth weight. High-risk groups (those with low capacity) clearly have most to gain from reducing their load. Some components of metabolic capacity are relatively fixed by early infancy, while other components will benefit from exercise and physical fitness throughout the life-course. Growth patterns in infancy and childhood are also very relevant.
Childhood under-nutrition
The capacity-load model was originally applied to understand associations of birth weight with NCD risk, and the findings have been relatively consistent across cohorts. The scenario for postnatal growth variability has received less attention, and the findings are more heterogeneous across populations.
In retrospective analyses of the UK Hertfordshire cohort, low weight at 1 year predicted elevated NCD risk [5] . This suggests that poor postnatal growth continues to constrain the development of metabolic capacity in early infancy, when hyperplasic growth is still occurring. The results of propsective randomized trials of infant formula-milk, in which groups with faster growth had higher NCD risk markers in childhood [15] , might appear to contradict this interpretation, but in fact they suggest that, in this context, rapid infant growth exacerbated metabolic load more than it benefitted metabolic capacity [11] . The same issue may apply to population differences in the association between early postnatal growth and adult body composition, discussed above. While the underlying physiological mechanisms remains poorly understood, it appears that infant growth can impact both metabolic capacity and metabolic load. Slow growth can constrain capacity, while rapid growth can elevate load, and specific populations differ in the relative magnitudes of these antagonistic effects [11] .
A further reason for extending the model to postnatal life is that birth weight is not routinely measured in most LMIC populations, as the majority of births take place outside hospital settings. Instead, data on nutritional status in early life relate primarily to stunting (low height) and wasting (low weight-for-height). In this context, overt malnutrition in childhood might indicate continued depletion of metabolic capacity; however, this hypothesis has received little attention.
A recent 7-year follow-up of children who had experienced severe acute malnutrition (SAM) in early life provides unique data on this issue [24] . Markers of growth, adiposity, physical function and NCD risk were compared between survivors of SAM and sibling/community controls in rural Malawi. Compared to controls, SAM survivors demonstrated shorter stature and leg length, lower lean mass and weaker grip strength, all indicating reduced metabolic capacity. Overall, they had similar adiposity but had reduced levels of peripheral adiposity and hence a more central fat distribution. There was little overt indication of increased NCD risk at this timepoint.
In the absence of high metabolic load, therefore, deficits in metabolic capacity emerging in association with SAM may remain latent, but should this population be exposed to obesogenic factors later in life, they may demonstrate elevated susceptibility to NCDs.
So far, this review has described the capacity-load model and its potential to integrate data on diverse risk factors within a broader framework to understand NCD aetiology. The next question is, can it help explain why NCD risk is so strongly associated with bio-social factors such as socioeconomic position (SEP), ethnicity and geography?
Socio-economic status
Higher rates of chronic disease in those of lower SEP are now well established in high-income countries (HICs). Those of poorer backgrounds tend to die earlier from these conditions and to experience more years of ill-health prior to death [25] . Importantly, disadvantaged groups not only tend to experience poorer nutrition and growth in early life but may also demonstrate less healthy lifestyles in adulthood, thus demonstrating susceptibility to both components of NCD risk. The capacity-load model may therefore help understand the 'social determinants of health inequalities' [26] .
Most populations show an inverse social gradient in birth weight, as illustrated for a Brazilian city in Fig. 2a [27] . In this population, the gradient persisted into postnatal life, with the offspring of low-income families gaining less weight in infancy. Figure 2b shows the consequences 19 years later, addressing any change in socio-economic circumstances after birth [28] . In both sexes, those who had never experienced poverty were tallest, while those who had remained poor throughout development were~4 cm shorter. Those whose socio-economic status had fallen since birth were taller than those who had started poor but subsequently experienced better conditions. This study highlights the pernicious lifelong effect on stature of being born into poverty.
Many studies show a similar social gradient in adult height, established in early life. For example, across 54 LMIC countries, women of higher status were found to be consistently taller [29] . Whereas height increased over time in the wealthier groups, suggesting improvements in infant health, in the poorer groups height either remained stable or declined over time. The summed effect was increasing height inequality over time.
Associations of SEP with birth weight and adult height indicate significant social gradients in metabolic capacity. One underlying mechanism is variability in organ phenotype, for example, height is associated with the size of various organs in adulthood [30] . However, poor socioeconomic circumstances during development have also been directly associated with epigenetic effects [31] . Through such mechanisms, the effects of early poverty may become locked into metabolism over the long term. However, this reflects only the first of two penalties, for many populations also show social gradients in metabolic load.
Until recently, obesity was restricted to affluent groups, and poorer groups remained shorter and thinner throughout the life-course. By the late twentieth century, the situation had reversed in HICs. Here obesity is now commoner among poorer groups and tends to show an inverse social gradient in adults and children, though adult data are more consistent in men than women [32] . Poorer groups also consume less healthy diets, are more likely to smoke and have lower levels of leisure-time physical activity.
Looking beyond HICs, the picture is more complex. Among the poorest countries, chronic disease risk factors remain clustered among the wealthy, and in the early stages of economic development, this effect is magnified. In the 1990s, for example, an international comparison of women and preschool children in LMICs found that obesity tended to increase in proportion with gross national product (GNP), and within populations, it was characteristic of wealthier individuals [33] . Other studies also describe a strong association between wealth and obesity in LMIC populations [34] .
As economic development consolidates, however, this pattern may reverse. One study in 2004 reported that, as GNP increases, obesity becomes commoner in those of low rather than high SEP, with the effect stronger for women than for men. Surprisingly, the GNP 'cross-over point' at which the association between obesity and SEP shifted was not indicative of affluence, being only $2500 per capita [35] . Other LMIC studies report that obesity remains commonest among the affluent, though it may be increasing fastest in poorer groups.
Obesity is a useful marker for unhealthy diet and sedentary behaviour and is closely associated with the NCD epidemic. However, these studies indicate that obesity has a complex association with economic development, and countries vary in terms of whether the rich or poor acquire the greatest metabolic load from this source.
Beyond obesity, other components of metabolic load also show social patterning in LMICs, though again with heterogeneity across studies. In many cases, wealthier groups still have priority access to foods and lifestyles promoting NCD risk, but poorer groups are experiencing increased exposure to some risk factors. In India, for example, the diet of urban slum dwellers typically incorporates junk food and predisposes to central adiposity and perturbed metabolism [36] . A study of informal settlements in Mumbai found that energy-dense snacks and sugary drinks were commonly given even to infants and toddlers [37] . More generally, smoking is more common among poor than rich groups, especially in men.
In HICs, there is a clearer inverse social gradient in NCD risk, and yet here too there is complexity, for socioeconomic position in many of these countries is associated with the ethnic composition of the population. The capacity-load model can likewise help explain ethnic variability in NCD risk.
Ethnicity
Ethnic differences in birth weight are well recognized in countries like Australia, South Africa, UK and US. Figure  3a shows differences of ethnic minorities relative to white European infants in a UK cohort born in 2000-2002. Average weight was lower, though variably so, in every ethnic minority, and the prevalence of low birth weight was greater [38] . Smaller maternal size, higher parity and slightly shorter pregnancies accounted for much of the difference in the Indian and Bangladeshi populations, while SEP and educational status also contributed for all groups [38] . This indicates that variability in metabolic capacity reflects the cumulative experience of earlier generations.
These differences, averaging 9-10% lower values in the South Asian populations, indicate deficits in metabolic capacity. Moreover, the magnitude of depletion of metabolic capacity may be greater than that in birth weight. Indian neonates from the city of Pune were found to be on average almost 1 kg lighter than British neonates of Fig. 2 Poverty and metabolic capacity in Brazil. a Association of birth weight and infant weight gain with family income, assessed in 'minimum wages' [27] (reproduced with permission from ref. [11] ). b Adult height according to whether the individual had always been wealthy (W), always poor (P) or had undergone improvement (U) or deterioration (D) between birth and adulthood [28] (reproduced with permission from ref. [11] ) Fig. 3 Ethnicity and the capacity-load model. a Deficits in birth weight and increased proportion of low birth weight (<2500 g) in ethnic minority groups relative to white Europeans in the UK Millennium cohort [38] (reproduced with permission from ref. [11] ). b Elevated fat mass for a given weight in UK infants of South Asian ancestry relative to Europeans (reproduced with permission from ref. [40]) European ancestry, but this deficit was unequally distributed across body components. While head circumference was reduced by~1.2 z-scores, weight and length were~1.5 zscores lower and abdominal circumference~2.3 z-scores lower. In contrast, triceps skinfold was reduced by~0.8 zscores and subscapular skinfold by only~0.3 z-scores [39] . Similar findings emerged from a UK study: at 3 months, South Asian infants were~220 g lighter than European infants but had~340 g less lean mass, and this deficit could be largely explained by their~500 g lower birth weight [40] . Indian babies have been described as having a 'thinfat' phenotype, preserving their brain growth and adiposity at a cost to other organs and muscle mass [39] . This can be considered an extreme form of the 'thrifty phenotype', implying a major deficit in metabolic capacity.
More generally, birth weight varies substantially across populations and systematically by global region, being higher in Western industrialized than in Asian, African or Central/South American populations [11] . Again, this implies variability in metabolic capacity. Although this may incorporate genetic effects, as indicated by studies of babies of mixed ethnic ancestry, environmental factors undoubtedly play a crucial role. Restricting analysis to high SEP populations, variability in foetal growth across countries is very modest, suggesting that cumulative exposure to contrasting environments across generations is the primary cause of inter-country variability.
As with birth weight, human populations also show substantial variability in adult nutritional status. Turkana pastoralists from Kenya average 168 and 177 cm in height in females and males, respectively, but have BMI <18.5 kg/ m 2 . Tongan Islanders differ negligibly in height from the Turkana, but with BMI of~30 kg/m 2 they have~70% more weight, much of the difference comprising adipose tissue [11] . Since organs track stature more strongly than weight, Tongan Islanders must impose a substantially greater metabolic load on their homeostatic capacity than the Turkana.
Both the amount and distribution of adipose tissue vary between ethnic groups. Imaging studies have demonstrated low levels of visceral fat in African Americans relative to Europeans, whereas South Asians have both higher total body fat content for a given BMI (Fig. 3b) and greater visceral fat [41] . Along with their lower birth weight, this excess adiposity is considered to account for much of the elevated NCD risk of South Asians relative to Europeans.
Beyond variability in the quantity and distribution of adipose tissue, ethnic groups also vary in its metabolic impact. In British schoolchildren, the association between adipose tissue and insulin resistance was stronger in South Asians compared to those of African/Caribbean or European ethnicity [42] . In other words, excess adiposity appears to be more 'toxic' for some ethnic groups. A plausible explanation may lie in the inflammatory factors secreted by adipose tissue, which not only promote immune function but also elevate cardiovascular risk. Several studies have reported ethnic differences in leptin and cytokine levels, which may reflect variability in both the anatomical distribution of adipose tissue and its inflammatory activity [11] .
Overall, such differences in body composition are strongly implicated in the variability in NCD risk that characterizes ethnic minority groups such as South Asians in the UK, African and Hispanic Americans in the USA, aboriginal or First Nation populations in Canada and Australia and Maori populations in New Zealand. Some populations seem to pay a greater metabolic penalty for obesity than others. In addition, ethnic groups may also vary in their lifestyles, though the heterogeneity is complex, and individual groups may change behaviour at different rates over time. Finally, ethnic minorities have often faced long-term prejudice and psychosocial stress, which may elevate metabolic load via chronic activation of the stress response.
Broadly, therefore, ethnic minority groups in HICs are characterized by lower metabolic capacity, and this is often exacerbated by elevated metabolic load. Ethnic differences in cytokine biology may exacerbate these effects, so that migrants born in pathogen-rich conditions who live as adults in industrialized settings may have three sources of elevated cardio-metabolic risk: lower capacity, elevated load, and a predisposition to inflammation.
Which of capacity and load is more important?
We should not expect the epidemiology observed in HICs to be replicated exactly in other regions for several reasons [11] . First, the relative contributions of capacity and load may differ. In HICs, the obesity epidemic in combination with western diets and sedentary behaviour indicates relatively high load in the majority of adults. Under this scenario, variability in birth weight helps explain variability disease risk, by indicating how well each individual can tolerate the high load.
In LMICs, in contrast, individuals vary substantially in the magnitude of metabolic load. In urban environments, many are overweight or obese, whereas in rural settings, average BMI remains much lower and chronic energy deficiency remains prevalent. Conversely, the majority were born with lower birth weights than HIC populations. This indicates a generic reduction in metabolic capacity and increases the susceptibility of entire populations to any elevation in metabolic load. In this scenario, NCD risk may be predicted better by load than by capacity and is strongly associated with urbanization. This may explain the high prevalence of diabetes in urban India, despite high BMI remaining relatively uncommon.
Second, infant growth patterns may shape NCD risk in contrasting ways. In HICs with high average birth weight, rapid infant weight gain is associated with later adiposity and elevated NCD risk. In India, Brazil and Guatemala, however, where average birth weight is lower, rapid infant weight gain was associated with greater height and lean mass in adulthood but negligbly with adiposity [43] . Infant weight gain may therefore benefit metabolic capacity in chronically undernourished populations but elevate load in populations who are already relatively well nourished.
As yet, most data are observational, and more studies are needed to determine whether promoting infant growth in LMIC populations would indeed reduce NCD risk. Two studies offer some support for this hypothesis. First, a community supplementation programme targeting pregnant women and children <7 years in Guatemala was associated both with improved childhood growth and with modest reductions in adult NCD risk. Further follow-ups are testing whether these benefits amplify with increasing age of the cohort [44] . Second, a similar supplementation programme in India was associated with reduced NCD risk in adolescents [45] . In each case, supplementation appeared to promote metabolic capacity without elevating load. The main limitation is that these studies did not involve randomization at the individual level and hence might be confounded by background differences between those supplemented versus controls.
Incorporating organ phenotype
The capacity-load model assumes that the structure and function of organs makes a key contribution to variability in NCD risk. Until recently, this was difficult to test empirically, but data are increasingly available. In the rat, a variety of organs were found to be smaller following foetal undernutrition, whereas the brain was relatively protected [46] . In humans, growth-retarded neonates likewise had reduced volumes of the kidney, liver and spleen [47] . A recent study in Nepal demonstrated that, independent of weight at birth and childhood fat mass, dimensions of the kidneys also explained variability in systolic blood pressure at 8 years [48] .
Whereas foetal organ development is very sensitive to the delivery of nutrients and oxygen, in postnatal life linear growth gradually loses sensitivity to nutrition and eventually comes under the canalizing control of growth hormone. From this point, organ growth closely follows growth in stature (Fig. 4a) [49] . The striking linearity of the relationships indicates a common regulatory system and helps explain why metabolic capacity tracks from early life into adulthood, where height remains associated with organ masses (Fig. 4b) [30] .
Such associations may also extend to ethnic differences. Autopsy data indicate that Indians have smaller organs than Europeans, even after adjusting for their shorter height, indicating a generic lower metabolic capacity [50] . Substantial variability in height and weight across ethnic groups may therefore index variability in organ mass, and hence metabolic capacity, as well as adipose tissue distribution, representing metabolic load, but this hypothesis requires further investigation.
Conclusion
The capacity-load model represents a broad conceptual framework for understanding the development of NCDs and their key risk factors. It complements detailed mechanistic research highlighting the role of very specific traits, enabling the integration of diverse types of data from multiple study designs. It may prove particularly valuable for research on the social determinants of health, the intergenerational transmission of NCD risk and understanding geographical and ethnic variability in NCD susceptibility. Fig. 4 Organ growth and linear growth. a Associations between height and mass of the kidney, liver and brain, based on autopsy data from children between birth and 12 years [49] (reproduced with permission from ref. [11] ). b Associations between height and mass of the pancreas, spleen and kidney in adult men and women [30] (reproduced with permission from ref. [11]) Future work will apply it to other NCD outcomes, such as cancer and infectious disease.
